Back to search results

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Psychosis Associated With Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Clinical Site, Phoenix, Arizona, United States

  • Clinical Site, Scottsdale, Arizona, United States

  • Clinical Site, Tucson, Arizona, United States

  • Clinical Site, Anaheim, California, United States

  • Clinical Site, Orange, California, United States

  • Clinical Site, San Diego, California, United States

  • Clinical Site, Boca Raton, Florida, United States

  • Clinical Site, Deerfield Beach, Florida, United States

  • Clinical Site, Doral, Florida, United States

  • Clinical Site, Homestead, Florida, United States

  • Clinical Site, Miami, Florida, United States

  • Clinical Site, Miami, Florida, United States

  • Clinical Site, Miami, Florida, United States

  • Clinical Site, Miami, Florida, United States

  • Clinical Site, Miami Gardens, Florida, United States

  • Clinical Site, Miami Gardens, Florida, United States

  • Clinical Site, Naples, Florida, United States

  • Clinical Site, Orlando, Florida, United States

  • Clinical Site, Tampa, Florida, United States

  • Clinical Site, West Palm Beach, Florida, United States

  • Clinical Site, Augusta, Georgia, United States

  • Clinical Site, Las Vegas, Nevada, United States

  • Clinical Site, West Long Branch, New Jersey, United States

  • Clinical Site, Dayton, Ohio, United States

  • Clinical Site, Independence, Ohio, United States

  • Clinical Site, Sugarland, Texas, United States

  • Clinical Site, Bellevue, Washington, United States

  • Clinical Site, Córdoba, Córdoba Province, Argentina

  • Clinical Site, Córdoba, Argentina

  • Clinical Site, Pernik, Pernik, Bulgaria

  • Clinical Site, Sofia, Sofia, Bulgaria

  • Clinical Site, Brampton, Ontario, Canada

  • Clinical Site, London, Ontario, Canada

  • Clinical Site, Toronto, Ontario, Canada

  • Clinical Site, Lévis, Quebec, Canada

  • Clinical Site, Choceň, Czechia

  • Clinical Site, Toulouse, France

  • Clinical Site, Bucharest, Romania

  • Clinical Site, Daegu, South Korea

  • Clinical Site, Incheon, South Korea

Study leads

  • MapLight Therapeutics

    Study Director

    MapLight Therapeutics

View source on ClinicalTrials.gov(opens in a new tab)